26 results

621 The Current Evidence and Future Direction of Adjuvant Treatment for Gastric Cancer in the Era of Precision Medicine
Jong Hyuk Yun, Yoon Young Choi, Jae-Ho Cheong
KMSID: 1516092377   Cancer Res Treat. 2025;57(3):621-634.   Published online 2025 January 23    DOI: http://dx.doi.org/10.4143/crt.2024.1222
      
635 Fraction of Cancer Attributable to Carcinogenic Drugs in Korea from 2015 to 2030
Woojin Lim, Soseul Sung, Youjin Hong, Sungji Moon, Sangjun Lee, Kyungsik Kim, Jung Eun Lee, Inah Kim, Kwang-Pil Ko, Sue K. Park
KMSID: 1516092383   Cancer Res Treat. 2025;57(3):635-648.   Published online 2024 November 6    DOI: http://dx.doi.org/10.4143/crt.2024.644
      
649 Estimation of Population Attributable Fraction by Hormone and Reproductive Factors on Female Cancer in the Republic of Korea, 2015 to 2030
Youjin Hong, Soseul Sung, Woojin Lim, Sungji Moon, Kwang-Pil Ko, Jung Eun Lee, Inah Kim, Sun Ha Jee, Sun-Seog Kweon, Min-Ho Shin, Sangmin Park, Seung-Ho Ryu, Sun Young Yang, Jeongseon Kim, Sang-Wook Yi, Yoon-Jung Choi, Jeong-Soo Im, Hong Gwan Seo, Sue K. Park
KMSID: 1516092389   Cancer Res Treat. 2025;57(3):649-658.   Published online 2024 November 19    DOI: http://dx.doi.org/10.4143/crt.2024.707
      
659 Associations of Financial Toxicity with Employment Concerns and Cancer-Related Distress: A Cross-Sectional Survey among Korean Working-Age Cancer Survivors
Hyun-Ju Seo, Dal-Lae Jin, Young Ae Kim, Su Jung Lee, Seok-Jun Yoon
KMSID: 1516092375   Cancer Res Treat. 2025;57(3):659-668.   Published online 2024 December 3    DOI: http://dx.doi.org/10.4143/crt.2024.090
      
669 Which Chemotherapy-Related Terms Were Difficult for Cancer Patients, and Who Would Have the Most Difficulties?
Mangyeong Lee, Nayeon Kim, Ho-Young Kim, Ayoung Lee, Junghee Yoon, Juhee Cho
KMSID: 1516092380   Cancer Res Treat. 2025;57(3):669-677.   Published online 2024 December 3    DOI: http://dx.doi.org/10.4143/crt.2024.485
      
678 Low-Dose Cyclophosphamide Enhances the Tumoricidal Effects of 5-Day Spacing Stereotactic Ablative Radiotherapy by Boosting Antitumor Immunity
Hyunkyung Kim, Seok-Joo Chun, Sojung Sun, Haeun Cho, Tae-Jin Kim, Yoon-Jin Lee, Eui Kyu Chie, Kwangmo Yang, Mi-Sook Kim
KMSID: 1516092395   Cancer Res Treat. 2025;57(3):678-692.   Published online 2024 November 8    DOI: http://dx.doi.org/10.4143/crt.2024.807
      
693 To Use or Not to Use: Temozolomide in Elderly Patients with IDH Wild-Type MGMT Promoter Unmethylated Glioblastoma Treated with Radiotherapy
Chan Woo Wee, Joo Ho Lee, Hye In Lee, Jina Kim, Jong Hee Chang, Seok-Gu Kang, Eui Hyun Kim, Ju Hyung Moon, Jaeho Cho, Chul-Kee Park, Chae-Yong Kim, Kihwan Hwang, Hong In Yoon, In Ah Kim
KMSID: 1516092398   Cancer Res Treat. 2025;57(3):693-700.   Published online 2024 November 11    DOI: http://dx.doi.org/10.4143/crt.2024.945
      
701 Phase II Trial of Neoadjuvant Docetaxel/Cisplatin/5-Fluorouracil Combined with Pegteograstim for Unresectable, Locally Advanced Sinonasal Squamous Cell Carcinoma: KCSG HN18-07
Bhumsuk Keam, Ho Jung An, Seong Hoon Shin, Min Kyoung Kim, Jung Hae Cho, Seyoung Seo, Sung-Bae Kim
KMSID: 1516092374   Cancer Res Treat. 2025;57(3):701-708.   Published online 2024 December 16    DOI: http://dx.doi.org/10.4143/crt.2024.1025
      
709 Clinical Impact of TP53 Mutations in Patients with Head and Neck Cancer Who Were Treated with Targeted Therapies or Immunotherapy
Eun Joo Kang, Shinwon Hwang, Yun-Gyoo Lee, Jong-Kwon Choi, Seong Hoon Shin, Yoon Hee Choi, Keun-Wook Lee, Hyun Woo Lee, Min Kyoung Kim, Seung Taek Lim, Hwan Jung Yun, Sang-Gon Park, Sangwoo Kim, Sung-Bae Kim, Hye Ryun Kim
KMSID: 1516092394   Cancer Res Treat. 2025;57(3):709-719.   Published online 2024 December 23    DOI: http://dx.doi.org/10.4143/crt.2024.836
      
720 Normal Brain-Sparing Radiotherapy versus Whole Brain Radiotherapy for Multiple Brain Metastasis from Non–Small Cell Lung Cancer
Sangjoon Park, Jaeho Cho, Kyung Hwan Kim, Hong In Yoon, Chang Geol Lee
KMSID: 1516092384   Cancer Res Treat. 2025;57(3):720-730.   Published online 2024 December 3    DOI: http://dx.doi.org/10.4143/crt.2024.679
      
731 Machine Learning–Based Prognostic Gene Signature for Early Triple-Negative Breast Cancer
Ju Won Kim, Jonghyun Lee, Sung Hak Lee, Sangjeong Ahn, Kyong Hwa Park
KMSID: 1516092396   Cancer Res Treat. 2025;57(3):731-740.   Published online 2024 November 19    DOI: http://dx.doi.org/10.4143/crt.2024.937
      
741 Evaluating the Effects of Mindfulness-Based Self-Help via an OTT Platform on Breast Cancer Patients Undergoing Radiotherapy: A Prospective Nonrandomized Controlled Trial
Hyejo Ryu, Si Nae You, Sohee Oh, Bora Kim, Jeong-Hyun Kim, In Ah Kim
KMSID: 1516092399   Cancer Res Treat. 2025;57(3):741-748.   Published online 2024 November 25    DOI: http://dx.doi.org/10.4143/crt.2024.955
      
749 Prognostic Performance of the Next-Generation Sequencing-Based Multigene Assay in Early Breast Cancer Patients Treated According to the 21-Gene Assay Results
Eunhye Kang, Jong-Ho Cheun, Jeeyeon Lee, Jiwon Koh, Hyunwoo Lee, Ji-Young Park, Hee Jin Lee, Byeongju Kang, Woong Ki Park, Jeongeun Son, Bumjoon Kim, Woosung Chung, Wonshik Han, Han-Byoel Lee, Sae Byul Lee, Jai Min Ryu
KMSID: 1516092376   Cancer Res Treat. 2025;57(3):749-759.   Published online 2024 December 23    DOI: http://dx.doi.org/10.4143/crt.2024.1035
      
760 Association of Pro-inflammatory Cytokines with Gastric Cancer Risk: A Case-Cohort Study
Seungju Baek, Eunjung Park, Eun Young Park
KMSID: 1516092388   Cancer Res Treat. 2025;57(3):760-769.   Published online 2024 November 19    DOI: http://dx.doi.org/10.4143/crt.2024.718
      
770 Predictive Value of the nProfiler 1 Assay for the Efficacy of Adjuvant S-1–Based Doublet Chemotherapy in Stage III Gastric Cancer: A Post-Hoc Analysis of a Randomized Phase III Trial
Dong Ki Lee, Choong-kun Lee, Hyo Song Kim, Sun Jin Sym, Dae Young Zang, Ki Hyang Kim, Joo Han Lim, Hae Su Kim, Kyung Hee Lee, Heon Yung Gee, Sun Young Rha, Hyunki Kim, Minkyu Jung
KMSID: 1516092385   Cancer Res Treat. 2025;57(3):770-780.   Published online 2024 November 12    DOI: http://dx.doi.org/10.4143/crt.2024.705
      
781 The Histone Deacetylase Inhibitor Entinostat Mediates HER2 Downregulation in Gastric Cancer, Providing the Basis for Its Particular Efficacy in HER2-Amplified Tumors and in Combination Therapies
Tamara Zenz, Robert Jenke, René Thieme, Tim Kahl, Hannes Borchardt, Ines Gockel, Finn K. Hansen, Achim Aigner, Thomas R. H. Büch
KMSID: 1516092382   Cancer Res Treat. 2025;57(3):781-802.   Published online 2024 December 10    DOI: http://dx.doi.org/10.4143/crt.2024.546
      
803 dentifying Anti-cancer Effects and Exploring the Mechanism of an MPS1/TTK Inhibitor in Gastric Cancer
Eunseo Kim, Woo Sun Kwon, Tae Soo Kim, Jihyun Hwang, Sunghwan Kim, Sun Young Rha
KMSID: 1516092387   Cancer Res Treat. 2025;57(3):803-820.   Published online 2024 December 12    DOI: http://dx.doi.org/10.4143/crt.2024.780
      
821 A Machine Learning Risk Prediction Model for Gastric Cancer with SHapley Additive exPlanations
Bomi Park, Chung Ho Kim, Jae Kwan Jun, Mina Suh, Kui Son Choi, Il Ju Choi, Hyun Jin Oh
KMSID: 1516092392   Cancer Res Treat. 2025;57(3):821-829.   Published online 2024 December 16    DOI: http://dx.doi.org/10.4143/crt.2024.843
      
830 Effectiveness and Safety of Regorafenib and TAS-102 in Patients with Metastatic Colorectal Cancer: A Nationwide Population-Based Study in Taiwan
Ya-Wen Chang, Chun-Nan Kuo, Chia-Lun Chang, Jason C. Hsu, Yu Ko
KMSID: 1516092379   Cancer Res Treat. 2025;57(3):830-839.   Published online 2024 November 18    DOI: http://dx.doi.org/10.4143/crt.2024.376
      
840 Relationships between the Microbiome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
Hye In Lee, Bum-Sup Jang, Ji Hyun Chang, Eunji Kim, Tae Hoon Lee, Jeong Hwan Park, Eui Kyu Chie
KMSID: 1516092381   Cancer Res Treat. 2025;57(3):840-851.   Published online 2024 December 16    DOI: http://dx.doi.org/10.4143/crt.2024.521
      
852 Role and Effectiveness of Hypofractionated Proton Beam Therapy and Combinations with Systemic Chemotherapy in Inoperable Extrahepatic Cholangiocarcinoma
Sung Uk Lee, Tae Hyun Kim, Sang Myung Woo, Jung Won Chun, Hyunjae Shin, Yu Ri Cho, Bo Hyun Kim, Young-Hwan Koh, Sang Soo Kim, Yang-Gun Suh, Sung Ho Moon, Woo Jin Lee
KMSID: 1516092393   Cancer Res Treat. 2025;57(3):852-864.   Published online 2024 December 17    DOI: http://dx.doi.org/10.4143/crt.2024.805
      
865 Time-Trend Analysis and Risk Factors for Niraparib-Induced Nausea and Vomiting in Ovarian Cancer: A Prospective Study
Young Wook Jeong, Dongkyu Eugene Kim, Ji Hyun Kim, Se Ik Kim, Hyeong In Ha, Sang-Yoon Park, Myong Cheol Lim
KMSID: 1516092397   Cancer Res Treat. 2025;57(3):865-872.   Published online 2024 November 4    DOI: http://dx.doi.org/10.4143/crt.2024.899
      
873 Unraveling the Genetic Landscape of Langerhans Cell Histiocytosis in Korean Patients: Comprehensive Insights from Mutational Profiles and Clinical Correlations
Kyung-Nam Koh, Ha Ra Jun, Ji-Young Lee, Ji Young Kim, Su Hyun Yoon, Young Kwon Koh, Sung Han Kang, Hyery Kim, Ho Joon Im, Sung-Min Chun
KMSID: 1516092391   Cancer Res Treat. 2025;57(3):873-882.   Published online 2024 December 24    DOI: http://dx.doi.org/10.4143/crt.2024.782
      
883 Real-World Effectiveness and Safety of Intravenous Daratumumab in Patients with Multiple Myeloma: A Multicenter, Observational Study from Korea
Youngil Koh, Sung-Soo Yoon, Kihyun Kim, Je-Jung Lee, Sung-Hoon Jung, Sang Eun Yoon, Sung-Soo Park, YoungJu Park, Soomin Yoon, Chang-Ki Min
KMSID: 1516092390   Cancer Res Treat. 2025;57(3):883-890.   Published online 2024 December 24    DOI: http://dx.doi.org/10.4143/crt.2024.781
      
891 Psychometric Validation of Sheffield Profile for Assessment and Referral to Care (SPARC) in Korean Cancer Patients
Hong Jun Kim, Eun Hee Jung, Jung Hye Kwon, Yu Jung Kim, Su-Jin Koh, Myung Ah Lee, Jung Hun Kang, Sun Young Rha, Eun Mi Nam, Sun Kyung Baek, Ha Yeon Lee, Hun Ho Song, Young-Woong Won, Hanbyul Lee
KMSID: 1516092386   Cancer Res Treat. 2025;57(3):891-898.   Published online 2024 December 5    DOI: http://dx.doi.org/10.4143/crt.2024.706
      
899 ALK Inhibition in a Patient with Inflammatory Myofibroblastic Tumor Harboring CARS1-ALK Fusion
Songji Choi, Miso Kim, Sheehyun Kim, Taekeun Park, Yoonjin Kwak, Jeong Mo Bae, Hongseok Yun, Jee Hyun Kim
KMSID: 1516092378   Cancer Res Treat. 2025;57(3):899-904.   Published online 2024 December 18    DOI: http://dx.doi.org/10.4143/crt.2024.1184
      
Articles from Cancer Research and Treatment are provided here courtesy of Korean Cancer Association